Table of Contents Author Guidelines Submit a Manuscript
TheScientificWorldJOURNAL
Volume 7, Pages 64-73
http://dx.doi.org/10.1100/tsw.2007.219
Mini-Review Article

An Emerging Role for the Delta Opioid Receptor in the Regulation of Mu Opioid Receptor Function

Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, NY 10029, USA

Received 25 June 2007; Revised 26 July 2007; Accepted 30 July 2007

Academic Editors: D. Shurtleff and S. Ferre

Copyright © 2007 Raphael Rozenfeld et al.

Citations to this Article [45 citations]

The following is the list of published articles that have cited the current article.

  • Sergi Ferré, “Heteromerization of G-protein-coupled receptors. Implications for central nervous system function and dysfunction,” TheScientificWorldJournal, vol. 7, no. 2, pp. 46–47, 2007. View at Publisher · View at Google Scholar
  • Agnati Luigi Francesco, Guidolin Diego, Genedani Susanna, Leo Giuseppina, Woods S. Amina, Ferre Sergi, Franco Rafael, and Fuxe Kjell, “Integrative Action of Receptor Mosaics: Relevance of Receptor Topology and Allosteric Modulators,” Journal Of Receptors And Signal Transduction, vol. 28, no. 6, pp. 543–565, 2008. View at Publisher · View at Google Scholar
  • Grégory Scherrer, Noritaka Imamachi, Yu-Qing Cao, Candice Contet, Françoise Mennicken, Dajan O'Donnell, Brigitte L. Kieffer, and Allan I. Basbaum, “Dissociation of the Opioid Receptor Mechanisms that Control Mechanical and Heat Pain,” Cell, vol. 137, no. 6, pp. 1148–1159, 2009. View at Publisher · View at Google Scholar
  • Chefer, and Shippenberg, “Augmentation of morphine-induced sensitization but reduction in morphine tolerance and reward in delta-opioid receptor knockout mice,” Neuropsychopharmacology, vol. 34, no. 4, pp. 887–898, 2009. View at Publisher · View at Google Scholar
  • Wei-Yan Xie, Yi He, Yan-Rui Yang, Ya-Fang Li, Kai Kang, Bao-Ming Xing, and Yun Wang, “Disruption of Cdk5-associated phosphorylation of residue threonine-161 of the δ-opioid receptor: Impaired receptor function and attenuated morphine antinociceptive tolerance,” Journal of Neuroscience, vol. 29, no. 11, pp. 3551–3564, 2009. View at Publisher · View at Google Scholar
  • Lauren C. Purington, Irina D. Pogozheva, John R. Traynor, and Henry I. Mosberg, “Pentapeptides displaying μ opioid receptor agonist and δ opioid receptor partial agonist/antagonist properties,” Journal of Medicinal Chemistry, vol. 52, no. 23, pp. 7724–7731, 2009. View at Publisher · View at Google Scholar
  • Jacquelyn Miller, Anika Agarwal, Lakshmi A. Devi, Kellen Fontanini, James A. Hamilton, Jean-Philippe Pin, Denis C. Shields, C. Arnold Spek, Thomas P. Sakmar, Athan Kuliopulos, and Stephen W. Hunt III, “Insider access: pepducin symposium explores a new approach to GPCR modulation,” Annals of the New York Academy of Sciences, vol. 1180, pp. E1–E12, 2009. View at Publisher · View at Google Scholar
  • Konstantinos Alfaras-Melainis, Ivone Gomes, Raphael Rozenfeld, Venetia Zachariou, and Lakshmi Devi, “Modulation of opioid receptor function by protein-protein interactions,” Frontiers in Bioscience, vol. 14, no. 9, pp. 3594–3607, 2009. View at Publisher · View at Google Scholar
  • Luigi F. Agnati, Diego Guidolin, Giuseppina Leo, Chiara Carone, Susanna Genedani, and Kjell Fuxe, “Receptor-receptor interactions: A novel concept in brain integration,” Progress in Neurobiology, vol. 90, no. 2, pp. 157–175, 2010. View at Publisher · View at Google Scholar
  • Sergi Ferre, Rafael Franco, Carmen Lluis, and Jose Luis Lanciego, “Prime Time for G-Protein-Coupled Receptor Heteromers as Therapeutic Targets for CNS disorders: The Dopamine D-1-D-3 Receptor Heteromer,” Cns & Neurological Disorders-Drug Targets, vol. 9, no. 5, pp. 596–600, 2010. View at Publisher · View at Google Scholar
  • Rafael Machado Rezende, Patrícia Paiva-Lima, Webster Glayser Pimenta Dos Reis, Vinícius Mesquita Camêlo, Y.S. Bakhle, and Janetti Nogueira de Francischi, “Celecoxib induces tolerance in a model of peripheral inflammatory pain in rats,” Neuropharmacology, vol. 59, no. 6, pp. 551–557, 2010. View at Publisher · View at Google Scholar
  • Jane Aldrich, “Opioid Peptides,” Bioactive Peptides, pp. 103–136, 2010. View at Publisher · View at Google Scholar
  • Luigi F. Agnati, Diego Guidolin, Jean Pierre Vilardaga, Francisco Ciruela, and Kjell Fuxe, “On the expanding terminology in the GPCR field: The meaning of receptor mosaics and receptor heteromers,” Journal of Receptors and Signal Transduction, vol. 30, no. 5, pp. 287–303, 2010. View at Publisher · View at Google Scholar
  • Raphael Rozenfeld, and Lakshmi A Devi, “Functional Role(s) of Dimeric Complexes Formed from G-Protein-Coupled Receptors,” Handbook of Cell Signaling, pp. 185–194, 2010. View at Publisher · View at Google Scholar
  • Zhiyong Wang, Jean-Guy Chabot, and Remi Quirion, “On the possible role of ERK, p38 and CaMKII in the regulation of CGRP expression in morphine-tolerant rats,” Molecular Pain, vol. 7, 2011. View at Publisher · View at Google Scholar
  • Jose Vargas, Bruno Cesar Feltes, Joice De Faria Poloni, Guido Lenz, and Diego Bonatto, “Senescence; An endogenous anticancer mechanism,” Frontiers in Bioscience, vol. 17, no. 7, pp. 2616–2643, 2011. View at Publisher · View at Google Scholar
  • Yu Wu, Rui Chen, Xiaojia Zhao, Aiping Li, Gang Li, and Jianwei Zhou, “JWA regulates chronic morphine dependence via the delta opioid receptor,” Biochemical and Biophysical Research Communications, vol. 409, no. 3, pp. 520–525, 2011. View at Publisher · View at Google Scholar
  • John J. Lowery, Tyler J. Raymond, Denise Giuvelis, Jean M. Bidlack, Robin Polt, and Edward J. Bilsky, “In vivo characterization of MMP-2200, a mixed δ/μ opioid agonist, in mice,” Journal of Pharmacology and Experimental Therapeutics, vol. 336, no. 3, pp. 767–778, 2011. View at Publisher · View at Google Scholar
  • Krishan Kumar, Ritika Goyal, Annu Mudgal, Anita Mohan, and Santosh Pasha, “YFa and analogs: Investigation of opioid receptors in smooth muscle contraction,” World Journal of Gastroenterology, vol. 17, no. 40, pp. 4523–4531, 2011. View at Publisher · View at Google Scholar
  • Grégory Scherrer, and Brigitte L. Kieffer, “A new approach to visualize endogenously expressed G protein-coupled receptors in tissues and living cells,” Neuromethods, vol. 60, pp. 105–131, 2011. View at Publisher · View at Google Scholar
  • Dipak K. Sarkar, Amitabha Sengupta, Changqing Zhang, Nadka Boyadjieva, and Sengottuvelan Murugan, “Opiate Antagonist Prevents mu- and delta-Opiate Receptor Dimerization to Facilitate Ability of Agonist to Control Ethanol-altered Natural Killer Cell Functions and Mammary Tumor Growth,” Journal Of Biological Chemistry, vol. 287, no. 20, pp. 16734–16747, 2012. View at Publisher · View at Google Scholar
  • Cristina M. Costantino, Ivone Gomes, Steven D. Stockton, Maribel P. Lim, and Lakshmi A. Devi, “Opioid receptor heteromers in analgesia,” Expert Reviews in Molecular Medicine, vol. 14, 2012. View at Publisher · View at Google Scholar
  • Hai-Jing Chen, Wei-Yan Xie, Fang Hu, Ying Zhang, Jun Wang, and Yun Wang, “Disruption of δ-opioid receptor phosphorylation at Threonine 161 attenuates morphine tolerance in rats with CFA-induced inflammatory hypersensitivity,” Neuroscience Bulletin, vol. 28, no. 2, pp. 182–192, 2012. View at Publisher · View at Google Scholar
  • Mellar P Davis, “Evidence from basic research for opioid combinations,” Expert Opinion on Drug Discovery, vol. 7, no. 2, pp. 165–178, 2012. View at Publisher · View at Google Scholar
  • Qiang Wu, Hui-Yan He, Yan-Ni Fu, Ling Liu, and Ming-Hui Cao, “Effects of chronic morphine treatment on EAAT3 expression in C6 cells and its mechanisms,” Chinese Pharmacological Bulletin, vol. 28, no. 11, pp. 1589–1593, 2012. View at Publisher · View at Google Scholar
  • Loralie Langman, Laura Bechtel, and Christopher P. Holstege, “Clinical Toxicology,” Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, pp. 1109–1188, 2012. View at Publisher · View at Google Scholar
  • Qiang Wu, Shuxuan Xia, Jing Lin, Dexiong Cao, Weiqiang Chen, Ling Liu, Yanni Fu, Jianjun Liang, and Minghui Cao, “Effects of the altered activity of δ-opioid receptor on the expression of glutamate transporter type 3 induced by chronic exposure to morphine,” Journal of the Neurological Sciences, 2013. View at Publisher · View at Google Scholar
  • Belén Gago, Kjell Fuxe, Stefan Brené, Zaida Díaz-Cabiale, María Dolores Reina-Sánchez, Diana Suárez-Boomgaard, Ruth Roales-Buján, Alejandra Valderrama-Carvajal, Adelaida de la Calle, and Alicia Rivera, “ Early modulation by the dopamine D 4 receptor of morphine-induced changes in the opioid peptide systems in the rat caudate putamen ,” Journal of Neuroscience Research, 2013. View at Publisher · View at Google Scholar
  • Manuel Lisardo Sánchez, Elena Vecino, and Rafael Coveñas, “Distribution of methionine-enkephalin in the minipig brainstem,” Journal of Chemical Neuroanatomy, vol. 50-51, pp. 1–10, 2013. View at Publisher · View at Google Scholar
  • Joanne M. Droney, Sophy K. Gretton, Hiroe Sato, Joy R. Ross, Ruth Branford, Kenneth I. Welsh, William Cookson, and Julia Riley, “Analgesia and central side-effects: two separate dimensions of morphine response,” British Journal of Clinical Pharmacology, vol. 75, no. 5, pp. 1340–1350, 2013. View at Publisher · View at Google Scholar
  • Jenny Molet, and Michel Pohl, “Gene-based approaches in pain research and exploration of new therapeutic targets and strategies,” European Journal of Pharmacology, 2013. View at Publisher · View at Google Scholar
  • Darius. P. Zlotos, Ralf Jockers, Erika Cecon, Silvia Rivara, and Paula A. Witt-Enderby, “ MT 1 and MT 2 Melatonin Receptors: Ligands, Models, Oligomers, and Therapeutic Potential ,” Journal of Medicinal Chemistry, pp. 131114125731007, 2013. View at Publisher · View at Google Scholar
  • Anand W. Mehendale, Mark P. Goldman, and Rachel P. Mehendale, “Opioid overuse pain syndrome (OOPS): The story of opioids, Prometheus unbound,” Journal of Opioid Management, vol. 9, no. 6, pp. 421–438, 2013. View at Publisher · View at Google Scholar
  • Sulie L. Chang, and Xiangqian Liupp. 477–508, 2013. View at Publisher · View at Google Scholar
  • Richard M. van Rijn, Jessica H. Harvey, Daniela I. Brissett, Julia N. DeFriel, and Jennifer L. Whistler, “Novel Screening Assay for the Selective Detection of G-Protein-Coupled Receptor Heteromer Signaling,” Journal Of Pharmacology And Experimental Therapeutics, vol. 344, no. 1, pp. 179–188, 2013. View at Publisher · View at Google Scholar
  • Dasiel O. Borroto-Escuela, Wilber Romero-Fernandez, Alicia Rivera, Kathleen Van Craenenbroeck, Alexander O. Tarakanov, Luigi F. Agnati, and Kjell Fuxe, “On the G-Protein-Coupled Receptor Heteromers and Their Allosteric Receptor-Receptor Interactions in the Central Nervous System: Focus on Their Role in Pain Modulation,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, pp. 1–17, 2013. View at Publisher · View at Google Scholar
  • Kris Rutten, Thomas M. Tzschentke, Thomas Koch, Klaus Schiene, and Thomas Christoph, “Pharmacogenomic study of the role of the nociceptin/orphanin FQ receptor and opioid receptors in diabetic hyperalgesia,” European Journal of Pharmacology, 2014. View at Publisher · View at Google Scholar
  • E W Ong, L Xue, M C Olmstead, and C M Cahill, “Prolonged morphine treatment alters δ opioid receptor post-internalization trafficking,” British Journal of Pharmacology, 2014. View at Publisher · View at Google Scholar
  • Renata Perlikowska, Davide Malfacini, Maria Camilla Cerlesi, Girolamo Calo’, Justyna Piekielna, Léonore Floriot, Tiphaine Henry, Jean Claude do-Rego, Csaba Tömböly, Alicja Kluczyk, and Anna Janecka, “Pharmacological characterization of endomorphin-2-based cyclic pentapeptides with methylated phenylalanine residues,” Peptides, 2014. View at Publisher · View at Google Scholar
  • Jessica P. Anand, Vanessa R. Porter-Barrus, Helen V. Waldschmidt, Larisa Yeomans, Irina D. Pogozheva, John R. Traynor, and Henry I. Mosberg, “Translation of structure-activity relationships from cyclic mixed efficacy opioid peptides to linear analogues,” Biopolymers, vol. 102, no. 1, pp. 107–114, 2014. View at Publisher · View at Google Scholar
  • J. F. Peppin, and R. B. Raffa, “Delta opioid agonists: a concise update on potential therapeutic applications,” Journal of Clinical Pharmacy and Therapeutics, vol. 40, no. 2, pp. 155–166, 2015. View at Publisher · View at Google Scholar
  • Ruben S. Vardanyan, James P. Cain, Saghar Mowlazadeh Haghighi, Vlad K. Kumirov, Mary I. McIntosh, Alexander J. Sandweiss, Frank Porreca, and Victor J. Hruby, “Synthesis and Investigation of Mixed μ-Opioid and δ-Opioid Agonists as Possible Bivalent Ligands for Treatment of Pain,” Journal of Heterocyclic Chemistry, 2016. View at Publisher · View at Google Scholar
  • Linlin Sun, Brianna M. Lutz, and Yuan-Xiang Tao, “Contribution of Spinal Cord mTORC1 to Chronic Opioid Tolerance and Hyperalgesia,” Neuropathology of Drug Addictions and Substance Misuse, pp. 482–489, 2016. View at Publisher · View at Google Scholar
  • Li-Jiao Geng, Guang-Ming Zhang, Hui-Min Liang, Xiao-Yan Shi, Chao-Gang Zhang, and Shu-Yan Wang, “By up-regulating μ- and δ-opioid receptors, neuron-restrictive silencer factor knockdown promotes neurological recovery after ischemia,” Oncotarget, vol. 8, no. 60, pp. 101012–101025, 2017. View at Publisher · View at Google Scholar
  • Jessica P. Anand, and Deanna Montgomery, “Multifunctional Opioid Ligands,” 2018. View at Publisher · View at Google Scholar